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Summary Metastases to axillary lymph nodes is an important factor in predicting prognosis and survival in
primary operable carcinoma of the breast. A series of post mastectomy lymph nodes (150 cases) was selected
in this retrospective study, in which the initial diagnosis had been no metastases by light microscopy and in
which a long follow-up was available (average 10 years). The original H&E sections from these cases were
immunostained to detect metastases which might not have been previously appreciated. The study was
performed using a cocktail of 5 monoclonal antibodies directed against epithelial antigens. The object was to
explore the possibility of detection of occult micrometastases by immunohistochemistry and to evaluate their
prognostic significance. Micrometastases with individual cells and cell clusters were readily detected by this
technique in 14% of all cases. It also became apparent towards the end of the study that micrometastases
could be detected with equal sensitivity by any one of the 5 monoclonal antibodies. Positive staining of
malignant cells was found to be more frequent in invasive lobular carcinoma (ILC) than in invasive ductal
carcinoma (IDC). However, for the IDC group a striking association was found between micrometastases and
both recurrence and survival rate. The ILC sample was considered too small for meaningful interpretation.
We recommend the use of immunohistochemical techniques using monoclonal antibodies for the detection of
occult metastases in lymph nodes to improve the prediction of recurrence and survival in invasive ductal
carcinoma of the breast.
It is now well established that the presence of axillary nodal
metastases is the most important prognostic factor in
primary operable breast cancer. But it has also been shown
that 15-20% of patients without lymph node metastases as
assessed by light microscopy have a recurrence within 10
years (Fisher et al., 1978a; Rosen et al., 1981a). Therefore
the detection of occult micrometastases may be important
for predicting recurrence of the disease. While serial sections
have improved the detection of micrometastases (ranging
from 8% to 24%), no significant correlation between
micrometastases and survival rate has been reported
(Pickren, 1961; Fisher et al., 1978a; Wilkinson et al., 1981).
Currently, the detection of micrometastases can be
improved by immunohistochemical staining on paraffin
embedded sections using polyclonal or monoclonal
antibodies against epithelial antigens. Several laboratories
have recently used these techniques to detect such micro-
metastases either in bone marrow (Redding et al., 1983) or
in lymph nodes (Sloane et al., 1980; Wells et al., 1984).
Sloane et al. (1980) using polyclonal antibody in 31 cases
found no more metastases than by conventional
examination. By contrast, Wells et al. (1984) studied 45
cases, with three monoclonal antibodies and found an
overall increase of 15% in the detection rate. However, in
this study the number of patients and follow-up was not
adequate to assess the prognostic value of micrometastases.
In this study, we have reviewed and studied 150 patients
with an average follow-up of 10 years, first to investigate the
diagnostic value of immunohistochemical staining in
detecting micrometastases and secondly to correlate their
presence with prognosis (recurrence and survival).
Materials and methods
A series of 162 consecutive patients operated for primary
carcinoma of the breast between 1965 and 1977 were selected
for study (N-, MO). All of these patients were treated by a
Patey type of mastectomy and axillary node dissection: 31
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(21%) were postoperatively irradiated and 9 (6%) received a
brief course of chemotherapy. All slides of tumours and
lymph nodes were reviewed to determine histologic tumour
type (WHO 1981) grading (Scarff-Bloom) and lymphatic
invasion. Twelve cases were excluded, 3 because of
inadequate material and 9 because micrometastases were
detected at this second examination. Finally, 150 cases were
included in this study. There were 9 patients among these
who developed a carcinoma in the second breast during
follow-up. They were considered to have primary carcinoma
of the second breast. Two of these 9 patients presented
recurrences and had to be excluded from the final analysis
because of the impossibility of determining the responsible
breast.
The mean number of lymph nodes in each case was 12
with a range from 4 to 29. The mean age of the patients was
57 years at operation with a range from 30 to 80 years. The
length of follow-up in our series is shown in Table I. The
average time of follow-up from surgery to death or end of
study was 10 years and the majority of these patients fell
into a 6-15 year period. The distribution of tumour size and
pathologic criteria are presented in Table II.
Excluding the recurrent contralateral cancers, the number
of recurrences was 15/150 (10%): 9 between 0 and 5 years, 6
between 5 and 10 years. The distribution of recurrences
according to clinical and pathological criteria is presented in
Table III. There was no statistically significant difference in
the recurrence rate between patients T1 or T2, between
patients with invasive ductal carcinoma (IDC) or invasive
lobular carcinoma (ILC), or between patients with or
without lymphatic invasion. When the cases were evaluated
by histologic grade, the differences in recurrence rate
Table I Years of follow-up
Years Number ofpatients Percentage
0-5 10 7
6-10 82 55
11-15 55 36
16-20 3 2
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Table II Distribution of tumour size and pathologic criteria
Criteria Number ofpatients Percentage
Tumour size To 3 2
Ti 70 47.5
T2 70 47.5
T3 3 2
T.,, 2 1
Histologic typea IDC 116 78.5
IDC-ID 6 4
ILC 21 14.5
Others 5 3
Gradeb I 21 15
II 80 56
III 41 29
Lymphatic invasion Present 29 20
Absent 119 80
'IDC =invasive ductal carcinoma; IDC-ID=invasive ductal
carcinoma with predominant intraductal component; ILC=invasive
lobular carcinoma. bInvasive component is too minimal to be graded
in 6 IDC-ID.
Table III Recurrence of tumour size and pathologic criteria
Criteria Recurrence Percentage
Tumour size To 0/3
T, 6/70 9
T2 8/70 11
T3 1/3
TX 0/2
Histologic type IDC 13/122 11
ILC 2/21 9.5
Histologic gradea I 0
II 7 9
III 7 17
Lymphatic invasion Present 2/29 7
Absent 13/119 11
aOne IDC-ID not graded.
between grade I-II and grade II-III were not statistically
significant, but were significant between grade I-111
(P=0.048). The number of patients who died from their
cancer was 11 (3 between 0 and 5 years, 6 between 6 and 10
years, 2 between 11 and 15 years) and 14 died of other
causes.
Monoclonal antibodies
To improve the sensitivity of detecting malignant cells, we
used a cocktail of 5 monoclonal antibodies directed against
epithelial cell antigens: anticytokeratin (KL1 Immunotech,
France) (Viac et al., 1983); anti-EMA (E29 Dako) (Cordell
et al., 1985); and HMFG1, HMFG2 and AUA1 antibodies
which were kindly provided by Dr W.F. Bodmer and
produced in the ICRF Laboratories, London (Taylor-
Papadimitriou et al., 1981; Arklie et al., 1981; Epenetos et
al., 1982).
Immunoperoxidase staining
The slides used for immunostaining were the original
diagnostic slides stained by haematoxylin-eosin. These were
the same sections in which metastases were considered to be
negative. Recuts from paraffin blocks might introduce
another element in the study, i.e. similar to serial sectioning.
Besides, the feasibility of using the original H&E sections
could well prove to be of some practical value. These slides
were immersed in toluene for one week to remove the
coverslip. They were rehydrated by successive baths in
absolute alcohol, 95% alcohol, chloroform, acetone, distilled
water and PBS. This treatment eliminates the cytoplasmic
stain but leaves the nuclear staining, thus avoiding the usual
need for counterstaining.
Before immunostaining, sections were first trypsinized
using 0.1% trypsin in 0.4% calcium chloride solution at
37°C for 8min. Endogenous peroxidase activity was
inhibited using 0.5% hydrogen peroxide in methanol for
10min. The sections were then stained with a three stage
immunoperoxidase procedure (Delsol et al., 1984). They were
incubated in turn with the cocktail of monoclonal antibodies
(30min), with peroxidase conjugated rabbit antimouse
immunoglobulins (Dako) 30min and with peroxidase
conjugated swine antirabbit immunoglobulins (Dako)
(30mn). Each step was separated by careful washings in PBS
buffer. Peroxidase activity was revealed by diaminobenzidine
tetrahydrochloride.
Statistical analysis
The statistical significance of differences in proportions was
studied by contingency tables and chi-square test. The
method of Kaplan and Meier was used in calculating
recurrence and survival curves. The logrank test was used to
examine the statistical significance of observed differences.
An observation was considered to be statistically significant
if P<0.05. Lastly, multivariate analyses were performed
according to a Cox model, to predict recurrences of clinical
and pathological criteria.
Results
Frequency ofmicrometastases detected by
immunohistochemistry
Micrometastases were unequivocally detected in 21 cases
(14%). Thirteen corresponded to invasive ductal carcinoma
(11% of IDC) and 8 to invasive lobular carcinoma (38% of
ILC). No relationship was found between the presence of
these occult micrometastases and histologic grade, lymphatic
invasion, or treatment, either in the entire series or in the
group of IDC alone.
In all cases, these readily detectable micrometastases were
composed of single cells or small cell clusters in the sub-
capsular sinuses (Figures I and 2). A particular aspect was
seen in ILC, with single cells disseminated throughout large
areas of lymphoid tissue (Figures 3 and 4). In some cases, a
Figure 1 Immunoperoxidase staining of an original
haematoxylin-eosin stained node section with cocktail of
monoclonal antibodies against epithelial cell determinants. A
stained cluster of malignant cells is seen in the sub-capsular sinus.
The breast carcinoma corresponded to an invasive ductal
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the cancer. No significant difference was found between the
presence of micrometastases and recurrence or survival rate
in this group of cases as a whole. However, a significant
difference was found in the IDC group when the cases were
evaluated by histological type (Figures 5 and 6). In the ILC
group, there were recurrences (2 cases) noted without
micrometastases and no recurrences in the group with micro-
metastases (8 cases). But the series was too small to permit
definitive conclusion.
Multivariate analyses (Cox model) were performed with
several factors: age, tumour size, grade, lymphatic invasion
and presence of micrometastases. The most significant factor
for both recurrence and survival was the presence of
micrometastases (P=0.001 and P=0.01 respectively). Grade
was also significant (recurrence: P=0.02, survival P=0.03).
The remaining factors were not significant.
Figure 2 High power field from another sub-capsular lymph
node micrometastasis detected by immunoperoxidase staining
(invasive ductal carcinoma).
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Figure 5 Micrometastases and survival of patients in the IDC
group.
Figure 3 Immunoperoxidase detection of single cells
disseminated throughout lymphoid tissue in lymph node
metastasis. The breast carcinoma corresponded to an invasive
lobular carcinoma. (Low power).
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Figure 4 High power from the case illustrated in Figure 3.
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Figure 6 Micrometastases and recurrence rate in the IDC
group.
Discussion
few plasma cells positive for anti-EMA antibodies were
found but they were easily identifiable from neoplastic cells
(Delsol et al., 1984).
Prognostic influence ofmicrometastases
The clinical course was studied by two variables, recurrence
rate and survival including only patients who had died from
The present study emphasizes the diagnostic value of
immunohistochemistry in detecting lymph node
micrometastases. As in the series of Wells et al. (1984), we
detected micrometastases by immunohistochemical staining
in 14% of lymph nodes which were found to be negative on
initial conventional examination. We found that the
immunohistochemical detection was more frequent in ILC
lymph nodes compared with IDC lymph nodes. These values
were also comparable to those of Wells et al. (1984). In ILC,
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single cells are disseminated among lymphocytes and are
often mistaken for histiocytes in routine sections, but
become quite obvious as neoplastic cells on immunostaining.
In IDC, metastatic cells are larger, irregular and often in
small clusters and are thus more readily visible by routine
staining. This probably accounts for the smaller percentage
of these tumour metastases detected in immunostained
sections.
In the past, several studies have shown that serial sections
of lymph nodes could increase the accuracy of metastasis
detection (De Mascarel et al., 1982; Pickren, 1961; Fisher et
al., 1978a; Wilkinson et al., 1981). However, these micro-
metastases are visible by conventional staining and therefore
are not in the same category as those detected by immuno-
histochemical staining. It is of particular interest that in the
present study, we successfully applied immunostaining
technique to the original H&E stained lymph node sections.
Survival of breast carcinoma has already been studied
according to detection methods and size of lymph node
metastases. No significant difference was found between
patients with micrometastases and those with no metastases,
either by routine procedures (Fisher et al., 1978b; Rosen,
1981b) or by serial section (Pickren, 1961; Fisher et al.,
1978a; Wilkinson et al., 1981). Our study based on immuno-
histochemical staining with monoclonal antibodies against
epithelial antigens, is the first to demonstrate the prognostic
influence of micrometastases detected in such a manner. A
significant relationship has been shown to exist between the
presence of micrometastases and recurrent disease or survival
in the IDC group. In the ILC group although the
detection rate of micrometastases was higher the survival
figures were not significant (at least in this small series).
The cost of such a procedure would obviously be reduced
by using a single antibody. Initially, we used a cocktail of 5
monoclonal antibodies for two reasons: to be certain of
staining all metastatic cells and to ensure an optimal
intensity of staining. Later investigation (data not shown)
showed that each of the five monoclonal antibodies
individually gave as good a staining reaction as the cocktail
so that any one may be used in routine practice.
We are grateful to Sir Walter Bodmer for providing samples of
antibodies HMFG1, HMFG2 and AUI antibodies and to B. Delteil
and J.F. Deridet for technical assistance. This work was supported
by a grant from the ARC (Association pour la Recherche sur le
Cancer).
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